Northwest Biotherapeutics (NWBO) Revenue Growth (5y) (2015 - 2026)
Northwest Biotherapeutics (NWBO) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Northwest Biotherapeutics | 272.75 Mn | 270.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.63% |
| Dec 31, 2025 | 5.96% |
| Sep 30, 2025 | -1.53% |
| Jun 30, 2025 | 130.81% |
| Mar 31, 2025 | -8.03% |
| Dec 31, 2024 | -23.76% |
| Sep 30, 2024 | -9.65% |
| Jun 30, 2024 | -2.57% |
| Mar 31, 2024 | -3.48% |
| Dec 31, 2023 | 24.46% |
| Sep 30, 2023 | -2.17% |
| Jun 30, 2023 | -6.28% |
| Mar 31, 2023 | 46.14% |
| Dec 31, 2022 | 79.54% |
| Sep 30, 2022 | 6.84% |
| Jun 30, 2022 | 40.22% |
| Mar 31, 2022 | 42.74% |
| Sep 30, 2021 | 17.09% |
| Jun 30, 2021 | 21.52% |
| Mar 31, 2021 | 0.25% |